Guidelines for Clinical Management of Premenstrual Syndrome.
10.5124/jkma.2005.48.5.465
- Author:
Doo Seok CHOI
1
Author Information
1. Department of Obstetrics and Gynecology, SungKyunKwan University School of Medicine, Samsung Medical Center, Korea. dschoi@smc.samsung.co.kr
- Publication Type:Original Article
- Keywords:
Premenstrual syndrome;
Non-pharmacologic treatment;
Pharmacologic treatment
- MeSH:
Cognitive Therapy;
Dietary Supplements;
Diuretics;
Female;
Humans;
Menstrual Cycle;
Patient Education as Topic;
Premenstrual Syndrome*;
Prostaglandin Antagonists
- From:Journal of the Korean Medical Association
2005;48(5):465-471
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Premenstrual syndrome(PMS) refers to a group of menstruation-related symptoms that impair daily activity and interpersonal relationship. The therapeutic modality for PMS consists of non-pharmacologic and pharmacologic treatment. Generally, after confirmation of PMS, a set of non-pharmacologic treatments is recommended before pharmacologic treatment. Patients can be benefited from non-pharmacological treatments such as patient education, cognitive therapy, behavioral therapy, and dietary supplementation. Pharmacologic therapy including psychotropic agents, diuretics, and prostaglandin inhibitors may be used, when PMS symptoms are not sufficiently improved after non-pharmacologic treatments, or when symptoms fit the diagnostic criteria of premenstrual dysphoric disorder(PMDD). When treatment fails, hormonal therapy to manipulate menstrual cycle may be considered, and several trials showed improvement of physical and mood symptoms.
